SynDiag s.r.l.

SynDiag s.r.l. manufactures the OvAi Focus, a diagnostic device specifically designed for gynecological applications. Based on the provided details, this device is likely used for imaging or analysis to support women’s health assessments. The company focuses on innovations in this niche, leveraging expertise in gynecology and oncology.

SynDiag s.r.l. is based in Italy, which means its devices are subject to the European Union’s medical device regulations. Since the OvAi Focus is registered in the EU’s eudamed database, it adheres to EU regulatory requirements, including classification under the Medical Device Regulation (MDR) or previous directives like the MDD. Italian manufacturers must comply with EU-wide standards to ensure their devices meet safety, performance, and quality criteria before being placed on the market.

The OvAi Focus is classified as a Class I medical device, which is the lowest risk category under EU regulations. This classification means the device poses minimal risk to patients and typically requires fewer regulatory controls compared to higher-risk classes. However, even Class I devices must still comply with essential safety and performance requirements, and manufacturers must ensure proper design controls, risk management, and conformity assessments to demonstrate compliance with EU regulations.

SynDiag’s devices, including the OvAi Focus, are listed in the eudamed database, which is the official EU registry for medical devices. Registration in eudamed indicates that the device has undergone the necessary regulatory processes to comply with EU requirements, such as classification, conformity assessment, and UDI (Unique Device Identification) assignment. This transparency allows healthcare professionals, regulators, and patients to verify the device’s legal status within the EU market.